{"filing":{"accession_number":"0001628908-26-000084","cik":"0001628908","ticker":"EVH","company_name":"Evolent Health, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"evh-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000084/evh-20260806.htm"},"events":[{"id":25917,"run_id":23532,"accession_number":"0001628908-26-000084","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release for Q2 2026 (three months ended June 30, 2026) filed under Item 2.02. The press release discloses comprehensive financial results including revenue of $652.5 million, net loss of $28.4 million, Adjusted EBITDA of $28.1 million, and updated 2026 guidance raising revenue to $2.6–$2.7 billion and tightening Adjusted EBITDA to $120–$135 million. The filing includes consolidated statements of operations and balance sheets, making this a standard quarterly earnings disclosure material to investors.","company_name":"Evolent Health, Inc.","ticker":"EVH","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26856,"accession_number":"0001628908-26-000084","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 (three months ended June 30, 2026) filed under Item 2.02. The press release discloses comprehensive financial results including revenue of $652.5 million, net loss of $28.4 million, Adjusted EBITDA of $28.1 million, and updated 2026 guidance raising revenue to $2.6–$2.7 billion and tightening Adjusted EBITDA to $120–$135 million. The filing includes consolidated statements of operations and balance sheets, making this a standard quarterly earnings disclosure material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:46:38.283734+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26856,"accession_number":"0001628908-26-000084","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 (three months ended June 30, 2026) filed under Item 2.02. The press release discloses comprehensive financial results including revenue of $652.5 million, net loss of $28.4 million, Adjusted EBITDA of $28.1 million, and updated 2026 guidance raising revenue to $2.6–$2.7 billion and tightening Adjusted EBITDA to $120–$135 million. The filing includes consolidated statements of operations and balance sheets, making this a standard quarterly earnings disclosure material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:46:38.283734+00:00","company_name":"Evolent Health, Inc.","ticker":"EVH","filing_date":"2026-08-06"}]}